Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration.
Horlocker
Terese T
TT
Burton
Allen W
AW
Connis
Richard T
RT
Hughes
Samuel C
SC
Nickinovich
David G
DG
Palmer
Craig M
CM
Pollock
Julia E
JE
Rathmell
James P
JP
Rosenquist
Richard W
RW
Swisher
Jeffrey L
JL
Wu
Christopher L
CL
D006801:Humans; D015360:Analgesia, Epidural / Q000009:adverse effects; D016058:Analgesia, Patient-Controlled; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects; D000765:Anesthesia, Conduction / Q000009:adverse effects; D003692:Delayed-Action Preparations; D019317:Evidence-Based Medicine; D005104:Expert Testimony; D005283:Fentanyl / Q000008:administration & dosage / Q000009:adverse effects; D009020:Morphine / Q000008:administration & dosage / Q000009:adverse effects; D019148:Neuromuscular Blockade / Q000009:adverse effects; D010102:Oxygen Inhalation Therapy; D012131:Respiratory Insufficiency / Q000139:chemically induced / Q000517:prevention & control / Q000628:therapy
D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D005283:Fentanyl; D009020:Morphine